Della Porta MG - Search Results

1

Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology.

D'Amico S, Dall'Olio D, Sala C, Dall'Olio L, Sauta E, Zampini M, Asti G, Lanino L, Maggioni G, Campagna A, Ubezio M, Russo A, Bicchieri ME, Riva E, Tentori CA, Travaglino E, Morandini P, Savevski V, Santoro A, Prada-Luengo I, Krogh A, Santini V, Kordasti S, Platzbecker U, Diez-Campelo M, Fenaux P, Haferlach T, Castellani G, Della Porta MG. D'Amico S, et al. Among authors: della porta mg. JCO Clin Cancer Inform. 2023 Jun;7:e2300021. doi: 10.1200/CCI.23.00021. JCO Clin Cancer Inform. 2023. PMID: 37390377 Free article.

2

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E, Maffioli M, Bernasconi P, Lazzarino M, Invernizzi R, Cazzola M. Malcovati L, et al. Among authors: della porta mg. Leukemia. 2005 May;19(5):776-83. doi: 10.1038/sj.leu.2403680. Leukemia. 2005. PMID: 15789068 Clinical Trial.

3

Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.

Invernizzi R, Travaglino E, Benatti C, Malcovati L, Della Porta M, Cazzola M, Ascari E. Invernizzi R, et al. Eur J Haematol. 2006 Jun;76(6):494-501. doi: 10.1111/j.0902-4441.2006.t01-1-EJH2588.x. Epub 2006 Mar 9. Eur J Haematol. 2006. PMID: 16529600

4

Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.

Travaglino E, Benatti C, Malcovati L, Della Porta MG, Gallì A, Bonetti E, Rosti V, Cazzola M, Invernizzi R. Travaglino E, et al. Among authors: della porta mg. Eur J Haematol. 2008 Mar;80(3):216-26. doi: 10.1111/j.1600-0609.2007.01012.x. Epub 2007 Dec 10. Eur J Haematol. 2008. PMID: 18081721

5

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.

Della Porta MG, Malcovati L, Boveri E, Travaglino E, Pietra D, Pascutto C, Passamonti F, Invernizzi R, Castello A, Magrini U, Lazzarino M, Cazzola M. Della Porta MG, et al. J Clin Oncol. 2009 Feb 10;27(5):754-62. doi: 10.1200/JCO.2008.18.2246. Epub 2008 Dec 22. J Clin Oncol. 2009. PMID: 19103730

6

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome.

Della Porta MG, Malcovati L, Strupp C, Ambaglio I, Kuendgen A, Zipperer E, Travaglino E, Invernizzi R, Pascutto C, Lazzarino M, Germing U, Cazzola M. Della Porta MG, et al. Haematologica. 2011 Mar;96(3):441-9. doi: 10.3324/haematol.2010.033506. Epub 2010 Dec 6. Haematologica. 2011. PMID: 21134982 Free PMC article.

7

Classification and prognostic evaluation of myelodysplastic syndromes.

Cazzola M, Della Porta MG, Travaglino E, Malcovati L. Cazzola M, et al. Among authors: della porta mg. Semin Oncol. 2011 Oct;38(5):627-34. doi: 10.1053/j.seminoncol.2011.04.007. Semin Oncol. 2011. PMID: 21943669 Review.

8

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.

Ambaglio I, Malcovati L, Papaemmanuil E, Laarakkers CM, Della Porta MG, Gallì A, Da Vià MC, Bono E, Ubezio M, Travaglino E, Albertini R, Campbell PJ, Swinkels DW, Cazzola M. Ambaglio I, et al. Among authors: della porta mg. Haematologica. 2013 Mar;98(3):420-3. doi: 10.3324/haematol.2012.077446. Epub 2013 Jan 8. Haematologica. 2013. PMID: 23300182 Free PMC article.

9

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.

Malcovati L, Papaemmanuil E, Ambaglio I, Elena C, Gallì A, Della Porta MG, Travaglino E, Pietra D, Pascutto C, Ubezio M, Bono E, Da Vià MC, Brisci A, Bruno F, Cremonesi L, Ferrari M, Boveri E, Invernizzi R, Campbell PJ, Cazzola M. Malcovati L, et al. Among authors: della porta mg. Blood. 2014 Aug 28;124(9):1513-21. doi: 10.1182/blood-2014-03-560227. Epub 2014 Jun 26. Blood. 2014. PMID: 24970933 Free PMC article.

10

Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications.

Invernizzi R, Travaglino E, Della Porta MG, Malcovati L, Gallì A, Bastia R, Ciola M, Ambaglio I, Boveri E, Rosti V, Cazzola M. Invernizzi R, et al. Among authors: della porta mg. Leuk Lymphoma. 2017 Jul;58(7):1711-1720. doi: 10.1080/10428194.2016.1262030. Epub 2016 Nov 29. Leuk Lymphoma. 2017. PMID: 27897450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page